福瑞股份:MASH新药上市进程加快 看好诊断设备持续放量

长城证券股份有...
Jul 11, 2025

预计2030 年MASH 药物市场规模将超300 亿美元。代谢功能障碍相关脂肪变性肝病(MAFLD)是一类肝脏中多余脂肪堆积(非酒精摄入)导致的疾病。随着疾病进展,肝脏产生炎症,导致不同程度纤维化或瘢痕的产生,进入代谢功能障碍相关脂肪性肝炎(MASH)。而长期处于MASH 状态可能导致肝硬化,死亡风险显著上升。据弗若斯特沙利文报告预计,MASH 药物市场规模到2030 年将增长至322 亿美元。...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10